Century Therapeutics, Inc. (IPSC) vs Q32 Bio Inc. (QTTB)

Century Therapeutics, Inc. and Q32 Bio Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Q32 Bio Inc. are of similar size ($273.4M and $263.5M). Century Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 3.1×. Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −307.3%. Across the 11 metrics below, Q32 Bio Inc. leads on 9 and Century Therapeutics, Inc. on 2.

Valuation

Metric IPSC QTTB Biotechnology median
P/E n/m 3.07 10.60
P/S 3.03 n/m 9.40
P/B 1.50 1.78 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.99 (13.63) 9.02
Earnings yield (55.03%) 32.54% (32.88%)
Free cash flow yield (25.31%) (6.84%) (23.13%)

Profitability

Metric IPSC QTTB Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.65%) 72.14% (51.96%)
Return on assets (38.41%) 37.13% (46.06%)
Return on invested capital (64.92%) 0.00% 0.00%

Growth

Metric IPSC QTTB Biotechnology median
Revenue growth (TTM) 8,286.72% (307.33%) 6.76%
EPS growth (last fiscal year) 91.30% 136.78% 29.88%
Revenue growth, 5-year CAGR — 100.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IPSC QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.28 20.30 4.97
Net debt to EBITDA 17.95 (2.21) 1.01

Dividend

Metric IPSC QTTB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IPSC QTTB Biotechnology median
Market cap 273.43m 263.46m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack